CClinicalTrials.gg
CompletedNCT01043770TRIMSUpdated Jan 30, 2020

The Reversal Intervention for Metabolic Syndrome Study

An interventional study of Group lifestyle education in Metabolic Syndrome, sponsored by University of Leicester. Completed at 1 site in United Kingdom. Open to participants aged 40 Years to 74 Years. Per ClinicalTrials.gov, last updated 2020-01-30.

Sponsored by University of Leicester · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
40 Years to 74 Years
Sex
All
01

Study summary

The aim of our study is to see if people with metabolic syndrome who attend a group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes, heart disease and strokes in the future.

Read the detailed description

People who have a combination of risk factors termed metabolic syndrome are at increased risk of developing diabetes, heart disease and strokes. Metabolic syndrome is a major public health concern requiring urgent action because 25% of the adult UK population fulfil the criteria, and this will increase as people continue to be less active and levels of overweight and obesity rise.

The aim of our study is to see if people with metabolic syndrome who attend a structured group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes and cardiovascular disease in the future. Overall, we hope to show that this type of education reduces the number of people who have metabolic syndrome.

Subjects recruited with metabolic syndrome will be randomised to intervention or control arms. The intervention arm will receive group education and the control group will receive routine care.

The results will inform primary prevention strategies in people from varied ethnic backgrounds who are at high risk of developing type-2 diabetes and cardiovascular disease.

02

Conditions studied

  • Metabolic Syndrome

Keywords

  • Metabolic syndrome
  • Primary prevention
  • Diabetes
  • Cardiovascular disease
  • Patient education
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

This study's enrollment of 82 is above the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

University of Leicester is the lead sponsor of 166 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 40 - 74 years inclusive
  • Registered with a general practice in Leicester City or Leicester County Primary Care Trust
  • Availability of data to allow diagnosis of MetS (IDF criteria) collected at a screening visit

Exclusion criteria

Exclusion Criteria:

  • Previous diagnosis of T2DM, CVD (stroke/cerebrovascular accident, transient ischaemic attack), peripheral arterial disease, or coronary heart disease (angina, myocardial infarction, coronary artery bypass surgery, angioplasty)
  • Life-limiting terminal illness
  • Pregnancy and/or breast feeding
  • Lack of capacity to give informed consent because of serious mental health problems or learning disability.
  • People who are housebound
  • Patients residing in nursing/care homes
  • Individuals who are unable to speak and understand English. (The intervention will be made appropriate for ethnically diverse populations, but individuals who are unable to understand, speak and read English will be excluded at this stage. However, if the self-management programme is found to be successful we would adapt it for non-English speakers.)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Group lifestyle education

    Multi-component behaviour change intervention

    Behavioral: Group lifestyle education

  • No intervention
    Routine care

    Routine care

Interventions

  • BehavioralGroup lifestyle education

    Structured group education programme based on lifestyle changes (dietary and increased physical activity)

06

What researchers measure

Primary outcomes

  1. The proportion of people in the intervention and control groups with prevalent metabolic syndrome according to the IDF criteria.

    Time frame: 12 months follow-up.

Secondary outcomes

  1. The prevalence of metabolic syndrome according to NCEP criteria

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  2. Changes in individual components of the metabolic syndrome (fasting plasma glucose, triglycerides, HDL cholesterol, blood pressure, waist circumference), and 2 hour glucose

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  3. Changes in biomarkers (hs-CRP, adiponectin, and insulin)

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  4. Changes in physical activity as measured by IPAQ and pedometer

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  5. Changes in dietary/nutritional intake measured by DINE

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  6. Changes in Framingham risk score

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  7. Changes in quality of life as measured by EuroQol EQ-5D

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  8. Changes in depression/anxiety as measured by HADS

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

  9. Changes in general self-efficacy as measured by GSE

    Time frame: Compared at baseline versus 12 months, and for the intervention group versus the control group

07

Study locations

1 site
  • University of Leicester
    Leicester, LE9 6PE, United Kingdom
08

References and documents

Publications

  • Dunkley AJ, Davies MJ, Stone MA, Taub NA, Troughton J, Yates T, Khunti K. The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data. Trials. 2011 May 4;12:107. doi: 10.1186/1745-6215-12-107. PubMed 21542913 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01043770
Lead sponsor
University of Leicester
Collaborators
University Hospitals, Leicester
Responsible party
Sponsor
First posted
Jan 7, 2010
Start date
Aug 2009
Primary completion
Aug 2011
Completion
Aug 2011
Last update
Jan 30, 2020

Study contacts

Kamlesh Khunti, MD, FRCGP
principal investigator · Diabetes Research Centre, University of Leicester
Melanie J Davies, MD, FRCP
principal investigator · Diabetes Research Centre, University of Leicester

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion